Why join Freenome?
Freenome is a high-growth biotech company developing tests to detect cancer using a standard blood draw. To do this, Freenome uses a multiomics platform that combines tumor and non-tumor signals with machine learning to find cancer in its earliest, most-treatable stages.
Cancer is relentless. This is why Freenome is building the clinical, economic, and operational evidence to drive cancer screening and save lives. Our first screening test is for colorectal cancer (CRC) and advanced adenomas, and it’s just the beginning.
Founded in 2014, Freenome has ~400 employees and continues to grow to match the scope of our ambitions to provide access to better screening and earlier cancer detection.
At Freenome, we aim to impact patients by empowering everyone to prevent, detect, and treat their disease. This, together with our high-performing culture of respect and cross-collaboration, is what motivates us to make every day count.
Become a Freenomer
Do you have what it takes to be a Freenomer? A “Freenomer” is a determined, mission-driven, results-oriented employee fueled by the opportunity to change the landscape of cancer and make a positive impact on patients’ lives. Freenomers bring their diverse experience, expertise, and personal perspective to solve problems and push to achieve what’s possible, one breakthrough at a time.
About this opportunity:
The Director, Product Management, CRC Screening will play a critical role in defining and delivering Freenome’s colorectal cancer (CRC) screening solutions to patients.
In this role, you will define the product strategy and user needs for CRC early detection blood tests that will support patients in need of screening. These CRC early detection blood tests will be used by providers to increase adherence to screening and, thereby, improve patient outcomes.
You will represent the customer perspective to internal-facing teams defining the CRC screening product line. You will help define the user needs through voice of customer research and analysis, set the product priorities based on value and impact, and collaborate on the go-to-market commercialization plan through cross-functional engagement.
The role reports to the Senior Director, Product Management. This role will be a Hybrid role based in our Brisbane, California headquarters.
What you’ll do:
Develop the product strategy & lifecycle roadmap for Freenome’s CRC screening solutions
Define the user needs for Freenome’s CRC early detection blood tests
Collaborate on the commercialization plan with cross-functional teams (e.g., medical affairs, marketing, sales)
Lead cross-functional teams to execute on the product. Bring strategic lens to:
Must haves:
Nice to haves:
Benefits and additional information:
The US target range of our base salary rate for new hires is $197,200 - $304,000. You will also be eligible to receive pre-IPO equity, cash bonuses, and a full range of medical, financial, and other benefits depending on the position offered. Please note that individual total compensation for this position will be determined at the Company’s sole discretion and may vary based on several factors, including but not limited to, location, skill level, years and depth of relevant experience, and education. We invite you to check out our career page @ freenome.com/job-openings/ for additional company information.
Freenome is proud to be an equal-opportunity employer, and we value diversity. Freenome does not discriminate on the basis of race, color, religion, marital status, age, national origin, ancestry, physical or mental disability, medical condition, pregnancy, genetic information, gender, sexual orientation, gender identity or expression, veteran status, or any other status protected under federal, state, or local law.
Applicants have rights under Federal Employment Laws.
#LI-HYBRID
